Prot #M12-356: A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-414 in Combination with Radiation Plus Temozolomide or Temozolomide Alone for Subjects with Glioblastoma Multiforme

Project: Research project

Project Details

StatusFinished
Effective start/end date12/6/13 → 12/6/17

Funding

  • AbbVie Inc. (Prot #M12-356)